跳至主要内容
临床试验/EUCTR2011-003248-36-CZ
EUCTR2011-003248-36-CZ进行中(未招募)1 期

The clinical significance of epigenetic factors research to refine the diagnosis, estimate prognosis and risk of recurrence after curative pancreatic cancer resection.

Central Military Hospital0 个研究点目标入组 120 人开始时间: 2011年7月25日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • patients with chronic pancreatitis
  • patients with pancreatic focal mass
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 60
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 60

排除标准

  • age under 18 years
  • pregnancy and lactation
  • disagreement with participation in the study
  • chronic pancreatitis without mass
  • patients with severe heart and pulmonary failure

研究者

相似试验

The clinical significance of genetics factors... | 临床试验